These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 2439147

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Kit ligand/mast cell growth factor-independent differentiation of mast cells in myelodysplasia and chronic myeloid leukemic blast crisis.
    Valent P, Spanblöchl E, Bankl HC, Sperr WR, Marosi C, Pirc-Danoewinata H, Virgolini I, Eichler HG, Agis H, Sillaber C.
    Blood; 1994 Dec 15; 84(12):4322-32. PubMed ID: 7527672
    [Abstract] [Full Text] [Related]

  • 3. [An evaluation of the prognostic significance of antigen CD95(Fas/APO-1) expression on the cells of patients with a myelodysplastic syndrome, acute myeloid leukemia and chronic myeloleukemia].
    Polosukhina ER, Kuznetsov SV, Logcheva NP, Zabotina TN, Tenuta MR, Shirin AD, Kaletin GI, Turkina AG, Tsvetaeva NV, Shishkin IuV, Kadagidze ZG, Khoroshko ND, Volkova MA, Baryshnikov AIu.
    Ter Arkh; 1998 Dec 15; 70(7):21-5. PubMed ID: 9742630
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Monoclonal antibodies ICO-02 to blast cell antigens in patients with chronic myeloleukemia in blast crisis].
    Baryshnikov AIu.
    Eksp Onkol; 1984 Dec 15; 6(5):53-5. PubMed ID: 6239771
    [Abstract] [Full Text] [Related]

  • 6. [Differential analysis of BM cell morphology, immunophenotypic, cytogenetic characters and prognosis between myeloblastic and lymphoblastic crisis of CML].
    Liu YL, Wang XN, Liu HS.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun 15; 22(3):629-33. PubMed ID: 24989266
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Early T-cell features in blast crisis of Ph1-positive chronic myeloid leukaemia.
    Cervantes F, Anegon I, Rozman C, Gallart T, Pereira A, Vives-Corrons JL, Casademont J, Urbano-Marquez A.
    Scand J Haematol; 1985 Jul 15; 35(1):71-6. PubMed ID: 3931208
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Immunophenotype of blast cells in chronic myeloid leukemia.
    Valiron O, Clemancey-Marcille G, Troesch A, Schweitzer A, Prenant M, Hollard D, Berthier R.
    Leuk Res; 1988 Jul 15; 12(10):861-72. PubMed ID: 3199845
    [Abstract] [Full Text] [Related]

  • 11. Graft-versus-leukemia target antigens in chronic myelogenous leukemia are expressed on myeloid progenitor cells.
    Wu CJ, Biernacki M, Kutok JL, Rogers S, Chen L, Yang XF, Soiffer RJ, Ritz J.
    Clin Cancer Res; 2005 Jun 15; 11(12):4504-11. PubMed ID: 15958636
    [Abstract] [Full Text] [Related]

  • 12. t(14;14)(q11;q32) in biphenotypic blastic phase of chronic myeloid leukemia.
    Dastugue N, Kuhlein E, Duchayne E, Roubinet F, Bourrouillou G, Attal M, Pris J, Colombies P.
    Blood; 1986 Oct 15; 68(4):949-53. PubMed ID: 3489495
    [Abstract] [Full Text] [Related]

  • 13. The expression of myeloid-specific antigens on myeloid leukemia cells: correlations with leukemia subclasses and implications for normal myeloid differentiation.
    Ball ED, Fanger MW.
    Blood; 1983 Mar 15; 61(3):456-63. PubMed ID: 6186318
    [Abstract] [Full Text] [Related]

  • 14. Cell lineage heterogeneity in blast crisis of chronic myeloid leukaemia.
    Bettelheim P, Lutz D, Majdic O, Paietta E, Haas O, Linkesch W, Neumann E, Lechner K, Knapp W.
    Br J Haematol; 1985 Mar 15; 59(3):395-409. PubMed ID: 3855651
    [Abstract] [Full Text] [Related]

  • 15. Differentiation patterns in the blastic phase of chronic myeloid leukemia.
    Griffin JD, Todd RF, Ritz J, Nadler LM, Canellos GP, Rosenthal D, Gallivan M, Beveridge RP, Weinstein H, Karp D, Schlossman SF.
    Blood; 1983 Jan 15; 61(1):85-91. PubMed ID: 6571717
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mixed phenotype (T/B/myeloid) extramedullary blast crisis as an initial presentation of chronic myelogenous leukemia.
    Qing X, Qing A, Ji P, French SW, Mason H.
    Exp Mol Pathol; 2018 Apr 15; 104(2):130-133. PubMed ID: 29501750
    [Abstract] [Full Text] [Related]

  • 18. [The immunophenotypic and cytogenetic characteristics of the blast cells in subvariants of acute myeloid leukemia].
    Isakova LM, Tretiak NN, Khromiak VN, Gordienko AI, Zverkova AS, Vakul'chuk AM.
    Tsitol Genet; 2000 Apr 15; 34(1):48-56. PubMed ID: 10808542
    [Abstract] [Full Text] [Related]

  • 19. Prediction of relapse of pediatric acute myeloid leukemia by use of multidimensional flow cytometry.
    Sievers EL, Lange BJ, Buckley JD, Smith FO, Wells DA, Daigneault-Creech CA, Shults KE, Bernstein ID, Loken MR.
    J Natl Cancer Inst; 1996 Oct 16; 88(20):1483-8. PubMed ID: 8841024
    [Abstract] [Full Text] [Related]

  • 20. Granulocyte colony-stimulating factor receptors on human acute leukemia: biphenotypic leukemic cells possess granulocyte colony-stimulating factor receptors.
    Shimoda K, Okamura S, Harada N, Ikematsu W, Kondo S, Kawasaki C, Tanaka T, Etou T, Akashi K, Okamura T.
    Cancer Res; 1992 Jun 01; 52(11):3052-5. PubMed ID: 1534271
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.